# Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

> **NCT04656678** · NA · UNKNOWN · sponsor: **Northwell Health** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Disease

## Interventions

- **DEVICE:** Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance

## Key facts

- **NCT ID:** NCT04656678
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-25
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04656678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04656678, "Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04656678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*